Conference Presentations, Posters & Abstracts
—
Recent Pharsight®
Contributions
Current
Archive
2010
May
Marier JF. Biomarkers and Exposure-Response Modeling: Turning PK/PD Data into Knowledge in Non-Clinical and Clinical Studies. [invited presentation]. To be presented at: Discovery to Development Symposium on Preclinical Oncology and Biomarkers. May 11, 2010; Montreal, Quebec.
March
Mouksassi S, Leonard P, Marier JF, Beliveau M . Allometric Scaling To Predict Clearance (CL) of a Recombinant Protein (ENB-0040) in Infants and Adults. [poster presentation]. To be presented at: Society of Toxicology 2010 Annual Meeting; March 7-11, 2010; Salt Lake City, Utah.
Jomphe C, Lemire I, Leonard P, Reimer ML, Marier JF, Beliveau M. Comparison of the Toxicokinetic (TK) parameters of a Recombinant Protein (ENB-0040) estimated by Non-Compartmental and Compartmental Population Analysis following multiples doses in rats. [poster presentation]. To be presented at: Society of Toxicology 2010 Annual Meeting; March 7-11, 2010; Salt Lake City, Utah.
Bruno R, Claret L. Modeling and Simulation of Clinical Tumor Progression Dynamics: Predicting Phase 3 Survival Outcomes from Tumor Size Measurements in Phase 2. [invited presentation]. To be presented at: ASCPT 2010 Annual Meeting; March 17-20, 2010; Atlanta, Georgia.
Pan CP, Marier JF, Mouksassi MS, Breitmeyer JB, Royal MA. POPULATION PHARMACOKINETICS OF INTRAVENOUS ACETAMINOPHEN IN NEONATES, INFANTS, CHILDREN AND ADOLESCENTS. [oral presentation]. To be presented at: ASCPT 2010 Annual Meeting; March 17-20, 2010; Atlanta, Georgia.
Gibbs J, Fredrickson J, Barbee T, Correa I, Smith B, Lin SL, Gibbs M . Quantitative Model of the Relationship between DPP-4 inhibition and Response: Meta-analysis of Alogliptin, Saxagliptin, Sitagliptin, and Vildagliptin Efficacy Results. [poster presentation]. To be presented at: ASCPT 2010 Annual Meeting; March 17-20, 2010; Atlanta, Georgia.
Monteleone JP, Dykstra KH, Lee B, McGuire BM, Berry S, Diaz G, Rhead W, Syplyviy V, Zupanets I, Gargosky S, Martinez A, Mokhtarani M, Scharschmidt B. GLYCEROL PHENYLBUTRYATE (HPN-100), A NOVEL INVESTIGATIONAL AMMONIA SCAVENGING AGENT, DEMONSTRATED UNIQUE BEHAVIOR BASED ON PHARMACOKINETIC / PHARMACODYNAMIC (PK/PD) MODELING. [poster presentation]. To be presented at: SOCIETY FOR INHERITED METABOLIC DISORDERS 2010 Annual Meeting; March 27-31, 2010; Albuquerque, New Mexico.
January
Bruno, R. Pharmacokinetics/pharmacodynamics of monoclonal antibody in Oncology. [invited presentation]. Presented at: 31st Annual EORTC-PAMM Group Meeting: Treatment Individualization of Cancer; January 27-30, 2009; Toulouse, France.
Archive